Precision Cancer Care: How Theranostics is Reshaping Treatment and Diagnostics

  Dr. Michael Morris, one of the founders of United Theranostics, whose mission is to make molecular imaging and radiopharmaceutical therapy accessible to all patients in a comfortable environment with the highest quality of care joins eHealth Radio and the Cancer Information and Health News Channels. Listen to interview with host Eric Michaels & guest Dr. Michael Morris discuss the following:

1. Given the advancements in PET radiopharmaceuticals, what promising areas do you foresee for future development, and how will new radiotracers enhance diagnostic capabilities and clinical utility in theranostics?
2. What specific scientific innovations or research initiatives is United Theranostics currently pursuing to advance radiopharmaceutical therapy and molecular imaging?
3. How does United Theranostics ensure broad patient access to cutting-edge radiopharmaceutical therapies and advanced molecular imaging in a community setting, especially considering the expansion of new centers?
4. With the recent FDA approval for expanded indications like Pluvicto by Novartis ® for mCRPC (metastatic castration-resistant prostate cancer), how is United Theranostics integrating these new treatments to improve patient outcomes at earlier disease stages?
5. What key elements differentiate United Theranostics' business model in the radiopharmaceutical and theranostics market, and how do you plan to sustain growth and innovation in this rapidly expanding field? 

Dr. Michael A. Morris, MD, MS, DABR, DABNM, DCI, is a visionary physician-scientist renowned for his contributions to nuclear medicine, diagnostic radiology, and clinical informatics. As a co-founder of United Theranostics and the Medical Director Glen Burnie, Maryland, Dr. Morris has been instrumental in advancing radiopharmaceutical therapies and molecular imaging techniques, particularly in the treatment of prostate cancer and neuroendocrine tumors. Dr. Morris's career is a testament to his unwavering commitment to advancing medical science and improving patient outcomes. Through his leadership at United Theranostics, extensive research contributions, and dedication to education, he continues to shape the future of nuclear medicine and radiopharmaceutical therapy. Website: https://www.unitedtheranostics.com People also listened to this: Growing up with Schizoid Personality Disorder: A Raucous, Sensitive Memoir Tells All